Key points
- Revenue from ordinary activities down 1.84% to $7,183,609
- Annual Recurring Revenue (ARR) increased by 5.5% to $6.674M
- Total Operating Expenses reduced by 9% to $8.577M
- Loss for the year attributable to the owners of Global Health Limited was $758,220
- No dividends were paid, recommended, or declared during the financial period
Full summary
Global Health Ltd announced its financial results for the year ended 30 June 2026. The company reported a slight decrease in revenue from ordinary activities by 1.84% to $7,183,609. However, the Annual Recurring Revenue (ARR) increased by 5.5% to $6.674 million, primarily driven by a 14.2% increase in subscription revenue. Total operating expenses were reduced by 9% to $8.577 million, and the company's EBITDA improved by 28% to ($545,000). The loss for the year attributable to the owners of Global Health Ltd was $758,220. The company did not pay, recommend, or declare any dividends during the financial period.
Guidance
FY2026 ARR increased by 5.5% to $6.674M, Total Operating Expenses reduced by 9% to $8.577M
Outlook
Global Health Ltd aims to increase profitability and market share in its major business sectors during the next financial year.